Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. NKTR
NKTR logo

NKTR

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NKTR News

Class Action Lawsuit Filed Against Nektar Therapeutics

7m agoGlobenewswire

Nektar Therapeutics Faces Class Action Lawsuit

2h agoGlobenewswire

Nektar Therapeutics Faces Class Action Lawsuit

4h agoGlobenewswire

Nektar Therapeutics Faces Class Action Lawsuit

9h agoNewsfilter

Class Action Lawsuit Announced for Nektar Therapeutics

1d agoPRnewswire

Nektar Therapeutics Faces Class Action Over Misleading Trial Results

1d agoPRnewswire

Nektar Therapeutics Faces Class Action Lawsuit

1d agoGlobenewswire

Shareholder Class Action Filed Against Nektar Therapeutics

1d agoGlobenewswire

Nektar Grants Stock Options to New Employees

3d agoPRnewswire

Nektar Grants Stock Options to New Employees Under Inducement Plan

3d agoNewsfilter

Nektar Grants Stock Options to New Employees Under Inducement Plan

3d agoYahoo Finance

Faruqi & Faruqi Investigates Nektar Securities Litigation

3d agoGlobenewswire

Nektar Therapeutics to Announce Q4 and Year-End 2025 Financial Results

Feb 26 2026PRnewswire

Nektar Therapeutics to Announce Q4 and Year-End 2025 Financial Results

Feb 26 2026Newsfilter

Nektar Therapeutics to Participate in Health Conferences

Feb 24 2026PRnewswire

Alopecia Areata Market Poised for Significant Growth

Feb 19 2026Newsfilter